201 related articles for article (PubMed ID: 23662442)
1. [Salvinorin A and related diterpenes--biological activity and potential therapeutic uses].
Piekielna J; Fichna J; Janecka A
Postepy Biochem; 2012; 58(4):485-91. PubMed ID: 23662442
[TBL] [Abstract][Full Text] [Related]
2. Selective natural kappa opioid and cannabinoid receptor agonists with a potential role in the treatment of gastrointestinal dysfunction.
Fichna J; Schicho R; Janecka A; Zjawiony JK; Storr M
Drug News Perspect; 2009 Sep; 22(7):383-92. PubMed ID: 19890495
[TBL] [Abstract][Full Text] [Related]
3. Neuropharmacology of the naturally occurring kappa-opioid hallucinogen salvinorin A.
Cunningham CW; Rothman RB; Prisinzano TE
Pharmacol Rev; 2011 Jun; 63(2):316-47. PubMed ID: 21444610
[TBL] [Abstract][Full Text] [Related]
4. A unique natural selective kappa-opioid receptor agonist, salvinorin A, and its roles in human therapeutics.
Cruz A; Domingos S; Gallardo E; Martinho A
Phytochemistry; 2017 May; 137():9-14. PubMed ID: 28190678
[TBL] [Abstract][Full Text] [Related]
5. Neo-clerodane diterpenes from the hallucinogenic sage Salvia divinorum.
Shirota O; Nagamatsu K; Sekita S
J Nat Prod; 2006 Dec; 69(12):1782-6. PubMed ID: 17190459
[TBL] [Abstract][Full Text] [Related]
6. Salvinorin A: from natural product to human therapeutics.
Vortherms TA; Roth BL
Mol Interv; 2006 Oct; 6(5):257-65. PubMed ID: 17035666
[TBL] [Abstract][Full Text] [Related]
7. Salvia divinorum: from Mazatec medicinal and hallucinogenic plant to emerging recreational drug.
Zawilska JB; Wojcieszak J
Hum Psychopharmacol; 2013 Sep; 28(5):403-12. PubMed ID: 23794315
[TBL] [Abstract][Full Text] [Related]
8. New neoclerodane diterpenoids isolated from the leaves of Salvia divinorum and their binding affinities for human kappa opioid receptors.
Lee DY; Ma Z; Liu-Chen LY; Wang Y; Chen Y; Carlezon WA; Cohen B
Bioorg Med Chem; 2005 Oct; 13(19):5635-9. PubMed ID: 16084728
[TBL] [Abstract][Full Text] [Related]
9. The hallucinogenic herb Salvia divinorum and its active ingredient salvinorin A inhibit enteric cholinergic transmission in the guinea-pig ileum.
Capasso R; Borrelli F; Capasso F; Siebert DJ; Stewart DJ; Zjawiony JK; Izzo AA
Neurogastroenterol Motil; 2006 Jan; 18(1):69-75. PubMed ID: 16371085
[TBL] [Abstract][Full Text] [Related]
10. Kappa-opioid receptor-selective dicarboxylic ester-derived salvinorin A ligands.
Polepally PR; White K; Vardy E; Roth BL; Ferreira D; Zjawiony JK
Bioorg Med Chem Lett; 2013 May; 23(10):2860-2. PubMed ID: 23587424
[TBL] [Abstract][Full Text] [Related]
11. Salvinorin A, an active component of the hallucinogenic sage salvia divinorum is a highly efficacious kappa-opioid receptor agonist: structural and functional considerations.
Chavkin C; Sud S; Jin W; Stewart J; Zjawiony JK; Siebert DJ; Toth BA; Hufeisen SJ; Roth BL
J Pharmacol Exp Ther; 2004 Mar; 308(3):1197-203. PubMed ID: 14718611
[TBL] [Abstract][Full Text] [Related]
12. Use of nonprohibited hallucinogenic plants: increasing relevance for public health? A case report and literature review on the consumption of Salvia divinorum (Diviner's Sage).
Bücheler R; Gleiter CH; Schwoerer P; Gaertner I
Pharmacopsychiatry; 2005 Jan; 38(1):1-5. PubMed ID: 15706458
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and κ-opioid receptor activity of furan-substituted salvinorin A analogues.
Riley AP; Groer CE; Young D; Ewald AW; Kivell BM; Prisinzano TE
J Med Chem; 2014 Dec; 57(24):10464-75. PubMed ID: 25426797
[TBL] [Abstract][Full Text] [Related]
14. The hallucinogenic herb Salvia divinorum and its active ingredient salvinorin A reduce inflammation-induced hypermotility in mice.
Capasso R; Borrelli F; Zjawiony J; Kutrzeba L; Aviello G; Sarnelli G; Capasso F; Izzo AA
Neurogastroenterol Motil; 2008 Feb; 20(2):142-8. PubMed ID: 17931335
[TBL] [Abstract][Full Text] [Related]
15. Synthetic studies of neoclerodane diterpenes from Salvia divinorum: semisynthesis of salvinicins A and B and other chemical transformations of salvinorin A.
Harding WW; Schmidt M; Tidgewell K; Kannan P; Holden KG; Gilmour B; Navarro H; Rothman RB; Prisinzano TE
J Nat Prod; 2006 Jan; 69(1):107-12. PubMed ID: 16441078
[TBL] [Abstract][Full Text] [Related]
16. Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist.
Roth BL; Baner K; Westkaemper R; Siebert D; Rice KC; Steinberg S; Ernsberger P; Rothman RB
Proc Natl Acad Sci U S A; 2002 Sep; 99(18):11934-9. PubMed ID: 12192085
[TBL] [Abstract][Full Text] [Related]
17. Salvia divinorum and the unique diterpene hallucinogen, Salvinorin (divinorin) A.
Valdés LJ
J Psychoactive Drugs; 1994; 26(3):277-83. PubMed ID: 7844657
[TBL] [Abstract][Full Text] [Related]
18. From local to global-fifty years of research on Salvia divinorum.
Casselman I; Nock CJ; Wohlmuth H; Weatherby RP; Heinrich M
J Ethnopharmacol; 2014 Feb; 151(2):768-83. PubMed ID: 24315983
[TBL] [Abstract][Full Text] [Related]
19. Synthetic studies of neoclerodane diterpenes from Salvia divinorum: preparation and opioid receptor activity of salvinicin analogues.
Simpson DS; Katavic PL; Lozama A; Harding WW; Parrish D; Deschamps JR; Dersch CM; Partilla JS; Rothman RB; Navarro H; Prisinzano TE
J Med Chem; 2007 Jul; 50(15):3596-603. PubMed ID: 17580847
[TBL] [Abstract][Full Text] [Related]
20. Lack of effect of sublingual salvinorin A, a naturally occurring kappa opioid, in humans: a placebo-controlled trial.
Mendelson JE; Coyle JR; Lopez JC; Baggott MJ; Flower K; Everhart ET; Munro TA; Galloway GP; Cohen BM
Psychopharmacology (Berl); 2011 Apr; 214(4):933-9. PubMed ID: 21140258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
